Kinex Pharmaceuticals LLC of BUFFALO, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-23. The offering totals $40.0M, of which $300K was reported sold. Industry: Biotechnology.
Showing 25 of 39 people.
| Name | Role | Location |
|---|---|---|
| Jean-Pierre Sommadossi | Director | Boston, MA |
| Lyn Dyster | Executive Officer | Lewiston, NY |
| David Hangauer | Executive Officer | Lancaster, NY |
| Michael Murphy | Director | New York, NY |
| Charles Lannon | Director | Williamsville, NY |
| James Hussey | Executive Officer | Austin, TX |
| Jeffrey Yordon | Executive Officer | Schaumburg, IL |
| Allen Barnett | Director | Avondale, PA |
| Allen Barnett | Executive Officer | Avondale, PA |
| Johnson Lau | Director | Xi'an, F4 |
| Johnson Lau | Executive Officer | Xi'an, F4 |
| Randoll Sze | Executive Officer | Buffalo, NY |
| Rudolf Kwan | Executive Officer | Buffalo, NY |
| Simon Pedder | Executive Officer | Charlotte, NC |
| Jinn Wu | Director | Princeton Junction, NJ |
| John Vierling | Director | Buffalo, NY |
| Benson Tsang | Director | Buffalo, NY |
| John Koh | Director | Buffalo, NY |
| Jordan Kanfer | Director | Buffalo, NY |
| Manson Fok | Director | Buffalo, NY |
| Stephanie Davis | Director | Buffalo, NY |
| William Zuo | Executive Officer | Buffalo, NY |
| Kim Campbell | Director | Buffalo, NY |
| SongYi Zhang | Director | Buffalo, NY |
| Simon Kwan Hung Pedder | Executive Officer | Buffalo, NY |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-12-11 | D | $60.4M | $60.4M |
| 2019-05-15 | D | $100.0M | $100.0M |
| 2018-07-17 | D | $50.0M | $50.0M |
| 2017-05-03 | D | $20.0M | $20.0M |
| 2016-10-07 | D | $50.0M | $37.9M |
| 2015-06-16 | D | $10.0M | $10.0M |
| 2015-06-16 | D/A | — | $74.4M |
| 2015-05-20 | D | $62.8M | $48.1M |
| 2012-08-06 | D | $40.0M | $5.0M |
| 2011-04-25 | D | $5.0M | $4.7M |
| 2010-02-03 | D/A | $6.0M | $4.1M |
| 2010-01-07 | D | $6.0M | $3.8M |